These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7328996)

  • 1. [Histological characteristics of tuberculous cavity treated with rifampicin--a comparative study with cases treated by primary drugs (author's transl)].
    Tanaka I; Iwai K
    Kekkaku; 1981 Jul; 56(7):355-60. PubMed ID: 7328996
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects of tuberculous meningitis in Surabaya.
    Chandra B
    Proc Aust Assoc Neurol; 1976; 13():73-81. PubMed ID: 1029010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K; Kino C
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
    Kreis B; Israël L; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative controlled trial of rimactane in pulmonary tuberculosis.
    Dormer BA
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):188. PubMed ID: 4895449
    [No Abstract]   [Full Text] [Related]  

  • 8. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
    Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J
    Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histological observation on the tuberculous lesions aggravated during rifampicin treatment (author's transl)].
    Iwai K; Kino C; Tsuchiya S; Kita R; Kinoshita T
    Kekkaku; 1979 Sep; 54(9):473-8. PubMed ID: 502155
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delayed results of treatment of pulmonary tuberculosis with rifampicin].
    Fréour P; Bernadou M; Chomy P
    Gruzlica; 1974 May; 42(5):439-42. PubMed ID: 4464235
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M; Tuchais E; Viallet S; Chauvet G
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of rifampicin and streptomycin on the concentrations of testosterone and cortisol in the blood of men (author's transl)].
    Nocke-Finck L; Breuer H; Reimers D
    J Clin Chem Clin Biochem; 1980 Dec; 18(12):897-9. PubMed ID: 7205148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
    Hashimoto T; Shimao T; Aoki M; Misawa H; Takasawa N; Shiozawa S
    Kekkaku; 1984 Jun; 59(6):369-76. PubMed ID: 6492547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.